Yahoo Web Search

Search results

1. Merck & Co., Inc.

   NYSE: MRK

   125.44

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   -2.68 (-2.09%)

   At close:4:01 PM EDTTue. Jul 16, 2024

   125.30 -0.14 (-0.11%)

   After hrs:7:59 PM EDTTue. Jul 16, 2024

   Delayed Quote (USD) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	127.87
     High	129.03
     Low	125.20

   • Mkt Cap	324.5B
     P/E (TTM)	142.55
     Div & Yield	3.08 & 2.40%

   • Prev. Close	128.12
     52 Wk. Low	99.14
     52 Wk. High	134.63

   More about MRK

   What analysts are saying

   Argus Bullish Published June 05 · Merck & Co. is a worldwide pharmaceutical company. Its major drugs include treatments in oncology and diabetes. The company also has a leading... Read more

   Top stories

   • MRK
     -2.09%

   Is Merck & Co., Inc. (MRK) Among the Best Blue Chip Dividend Stock to Buy Right Now?

   Yahoo Finance · 1 week ago

   

   • AMNF
     +1.11%
   • DIT
     +3.29%
   • XOM
     +0.72%
   • MRK
     -2.09%
   • FMX
   • AMXOF
   • AMX
   • FMXUF

   Top Research Reports for Exxon Mobil, Merck & Qualcomm

   Yahoo Finance · 4 days ago

   

   • MRK
     -2.09%
   • ABBV
     +0.70%

   Merck's (MRK) Lung Cancer Candidate Faces FDA Rejection

   Yahoo Finance · 3 weeks ago

   

   Related stocks

   • PFE
     Pfizer Inc.
     PFE
     29.50
     +1.37%
   • JNJ
     Johnson & Johnson
     JNJ
     151.01
     +1.19%
   • PG
     The Procter & Gamble Company
     PG
     166.95
     +1.44%
   • BMY
     Bristol-Myers Squibb Company
     BMY
     41.20
     +2.62%
   • VZ
     Verizon Communications Inc.
     VZ
     41.45
     +1.62%

   More on Yahoo Finance

2. www.bloomberg.com › quote › MRK:USMRK: Merck & Co Inc Stock Price Quote - New York - Bloomberg

   www.bloomberg.com › quote › MRK:US

   • Cached

   1 day ago · Stock analysis for Merck & Co Inc (MRK:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

   • Employees: 70K

3. stockanalysis.com › stocks › mrkMerck & Co., Inc. (MRK) Stock Price, Quote & News - Stock ...

   stockanalysis.com › stocks › mrk

   • Cached

   6 days ago · Get a real-time Merck & Co., Inc. (MRK) stock price quote with breaking news, financials, statistics, charts and more.

   • Market Cap: 323.95B
   • Revenue (ttm): 61.40B

   • Net Income (ttm): 2.31B
   • Shares Out: 2.53B

4. www.morningstar.com › stocks › xnysMRK Stock Price Quote | Morningstar

   www.morningstar.com › stocks › xnys

   • Cached

   5 days ago · See the latest Merck & Co Inc stock price (MRK:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

5. stockanalysis.com › stocks › mrkMerck & Co., Inc. (MRK) Company Profile & Overview - Stock ...

   stockanalysis.com › stocks › mrk

   • Cached

   5 days ago · Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion ...

6. seekingalpha.com › symbol › MRKMerck & Co., Inc. (MRK) Stock Price, Quote, News & Analysis

   seekingalpha.com › symbol › MRK

   • Cached

   5 days ago · A high-level overview of Merck & Co., Inc. (MRK) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

   • Company name: Johnson & Johnson
   • Industry: Pharmaceuticals

   • Employees: 131,900
   • Market Cap: 350.63B

7. www.marketscreener.com › quote › stockMerck & Co., Inc. Stock (MRK) - Quote Nyse- MarketScreener

   www.marketscreener.com › quote › stock

   • Cached

   2 days ago · Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and ...

8. People also ask

   Who owns Merck & Co?

   • Merck & Co., Inc.'s stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (9.60%), Price T Rowe Associates Inc. MD (1.17%), Bank of New York Mellon Corp (0.78%), Capital World Investors (0.55%), Janus Henderson Group PLC (0.41%) and Raymond James & Associates (0.39%).

   Merck & Co., Inc. (MRK) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/NYSE/MRK/

   See all results for this question

   Is Merck a good stock to buy?

   • Merck's strong focus on research and development ensures a pipeline of innovative products, potentially leading to future revenue growth. Recent positive analyst ratings and price target increases indicate confidence in Merck's performance and potential stock price growth.

   Merck & Co., Inc. (MRK) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/NYSE/MRK/

   See all results for this question

   What factors affect Merck's stock price?

   • Market volatility and macroeconomic factors could affect Merck's stock price, leading to short-term fluctuations and potential investor uncertainty. The healthcare sector's sensitivity to political and regulatory changes could introduce unpredictability in Merck's operations and financial performance.

   Merck & Co., Inc. (MRK) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/NYSE/MRK/

   See all results for this question

   Should you buy Merck & Co (MRK)?

   • 13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merck & Co., Inc. in the last year. There are currently 1 sell rating, 3 hold ratings, 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" MRK shares.

   Merck & Co., Inc. (MRK) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/NYSE/MRK/

   See all results for this question

9. www.marketbeat.com › stocks › NYSEMerck & Co., Inc. (MRK) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com › stocks › NYSE

   • Cached

   1 day ago · Merck's current stock price of $123.80 presents a potential buying opportunity for investors looking to enter the market at a lower price point. The company's diverse portfolio of pharmaceutical products and ongoing research and development efforts position it well for future growth and innovation.